| Cancer immunotherapy via synergistic coactivation of myeloid receptors CD40 and Dectin-1 MM Wattenberg, H Coho, VM Herrera, K Graham, ML Stone, Y Xue, ... Science immunology 8 (89), eadj5097, 2023 | 19 | 2023 |
| Hepatocytes coordinate immune evasion in cancer via release of serum amyloid A proteins ML Stone, J Lee, JW Lee, H Coho, M Tariveranmoshabad, ... Nature Immunology, 1-9, 2024 | 12 | 2024 |
| Intratumoral Cell Neighborhoods Coordinate Outcomes in Pancreatic Ductal Adenocarcinoma MM Wattenberg, S Colby, I Garrido-Laguna, Y Xue, R Chang, D Delman, ... Gastroenterology 166 (6), 1114-1129, 2024 | 8 | 2024 |
| Multimodal immune phenotyping reveals microbial-T cell interactions that shape pancreatic cancer Y Li, RB Chang, ML Stone, D Delman, K Markowitz, Y Xue, H Coho, ... Cell Reports Medicine 5 (2), 2024 | 7 | 2024 |
| Immunologic predictors of therapeutic response to neoadjuvant chemotherapy for pancreatic ductal adenocarcinoma (PDA) in SWOG S1505. D Sohal, MT Duong, R Chang, Y Xue, D Delman, I Garrido-Laguna, ... Journal of Clinical Oncology 39 (3_suppl), 419-419, 2021 | 3 | 2021 |
| Combined loss of the chromosome 7 genes CUX1 and EZH2 promotes chemotherapy resistance MR Jotte, A Stoddart, TC Martinez, Y Xue, MK Imgruet, ME McNerney Cancer Research 84 (6_Supplement), 5598-5598, 2024 | | 2024 |
| Abstract B030: Spatial coupling of microbes and immune cells shapes the tumor microenvironment in human cancers Y Li, RB Chang, ML Stone, Y Xue, H Coho, K Markowitz, D Patel, ... Cancer Research 84 (2_Supplement), B030-B030, 2024 | | 2024 |
| Co-activation of myeloid signaling pathways for pancreatic cancer immunotherapy. MM Wattenberg, H Coho, VM Herrera, K Graham, ML Stone, Y Xue, ... CANCER RESEARCH 82 (22), 123-124, 2022 | | 2022 |
| Abstract C018: Co-activation of myeloid signaling pathways for pancreatic cancer immunotherapy MM Wattenberg, H Coho, VM Herrera, K Graham, ML Stone, Y Xue, ... Cancer Research 82 (22_Supplement), C018-C018, 2022 | | 2022 |
